PTDSS1

Chr 8AD

phosphatidylserine synthase 1

Also known as: LMHD, PSS1, PSSA

The protein encoded by this gene catalyzes the formation of phosphatidylserine from either phosphatidylcholine or phosphatidylethanolamine. Phosphatidylserine localizes to the mitochondria-associated membrane of the endoplasmic reticulum, where it serves a structural role as well as a signaling role. Defects in this gene are a cause of Lenz-Majewski hyperostotic dwarfism. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2014]

GeneReviewsOMIMResearchGenerating clinical summary…
GOFmechanismADLOEUF 0.451 OMIM phenotype
Clinical SummaryPTDSS1
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.25) despite low pLI — interpret in context.
📋
ClinVar Variants
8 unique Pathogenic / Likely Pathogenic· 105 VUS of 295 total submissions
📖
GeneReview available — PTDSS1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.45LOEUF
pLI 0.151
Z-score 3.95
OE 0.25 (0.140.45)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
2.38Z-score
OE missense 0.59 (0.520.67)
158 obs / 267.4 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.25 (0.140.45)
00.351.4
Missense OE?0.59 (0.520.67)
00.61.4
Synonymous OE?0.94
01.21.6
LoF obs/exp: 8 / 32.2Missense obs/exp: 158 / 267.4Syn Z: 0.47
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitivePTDSS1-related Lenz-Majewski hyperostotic dwarfismGOFAD
limitedPTDSS1-related developmental delayOTHERAD

This gene — mechanism propensity

DN
0.6744th %ile
GOF
0.6736th %ile
LOF
0.3551th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function, dominant-negative and loss-of-function). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports gain-of-function. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation
DNprediction above median
LOF1 literature citation · LOEUF 0.45

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFGain-of-function mutations in the phosphatidylserine synthase 1 (PTDSS1) gene cause Lenz-Majewski syndrome.1
LOFThis is the first report of the clinical phenotype seen in an individual with a heterozygous loss-of-function variant in PTDSS1.2

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

295 submitted variants in ClinVar

Classification Summary

Pathogenic5
Likely Pathogenic3
VUS105
Likely Benign99
Benign43
Conflicting6
5
Pathogenic
3
Likely Pathogenic
105
VUS
99
Likely Benign
43
Benign
6
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
5
0
0
5
Likely Pathogenic
0
3
0
0
3
VUS
8
90
5
2
105
Likely Benign
1
13
38
47
99
Benign
0
5
34
4
43
Conflicting
6
Total91167753261

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

38 pathogenic / likely-pathogenic (of 41) ClinVar copy-number / structural variants overlap PTDSS1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PTDSS1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →